An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?

E Moorkens, Arnold Vulto, I Huys

Pharmacy

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

42 Downloads (Pure)

Original language	English
Article number	Unsp 1743517
Journal	mAbs
Volume	12
Issue number	1
DOIs	https://doi.org/10.1080/19420862.2020.1743517
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1080/19420862.2020.1743517

Repub_126480_O-A.pdfFinal published version, 1.68 MB

Cite this

@article{b32a37aab91d460a82c144dd3c241509,

title = "An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?",

author = "E Moorkens and Arnold Vulto and I Huys",

year = "2020",

doi = "10.1080/19420862.2020.1743517",

language = "English",

volume = "12",

journal = "mAbs",

issn = "1942-0862",

publisher = "Landes Bioscience",

number = "1",

}

TY - JOUR

T1 - An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?

AU - Moorkens, E

AU - Vulto, Arnold

AU - Huys, I

PY - 2020

Y1 - 2020

U2 - 10.1080/19420862.2020.1743517

DO - 10.1080/19420862.2020.1743517

M3 - Article

C2 - 32306833

SN - 1942-0862

VL - 12

JO - mAbs

JF - mAbs

IS - 1

M1 - Unsp 1743517

ER -